Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2′-deoxyuridine
- 1 September 1994
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 120 (9) , 545-549
- https://doi.org/10.1007/bf01221032
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of (E)-5-(2-bromovinyl)-2′-deoxyuridine on life-span and 5-fluorouracil metabolism in mice with hepatic metastasesEuropean Journal of Cancer and Clinical Oncology, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Bioanalysis of fluorouracil applying liquid chromatography and valve switchingChromatographia, 1988
- Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in miceBiochemical Pharmacology, 1988
- Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing miceCancer Letters, 1988
- Bioanalysis of (E)-5-(2-bromovinyl)-2′-deoxyuridineJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.Journal of Clinical Investigation, 1988
- Non-linear pharmacokihetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracilBiochemical Pharmacology, 1986
- Oral (E)-5-(2-Bromovinyl)-2′-Deoxyuridine treatment of severe herpes zoster in cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.Proceedings of the National Academy of Sciences, 1979